Gland Pharma Limited (BOM:543245)
India flag India · Delayed Price · Currency is INR
2,313.30
+6.55 (0.28%)
At close: May 27, 2026

Gland Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
381,082279,443262,358303,932208,882537,705
Market Cap Growth
62.20%6.51%-13.68%45.50%-61.15%32.63%
Enterprise Value
349,589250,447236,321286,055175,977508,469
Last Close Price
2313.301697.301577.511806.281244.073205.93
PE Ratio
37.0927.2037.5639.3526.7444.38
PS Ratio
5.934.354.675.375.7612.22
PB Ratio
3.682.702.873.482.637.51
P/TBV Ratio
3.832.812.983.632.637.53
P/FCF Ratio
70.4951.6949.4850.08146.03192.42
P/OCF Ratio
36.9527.0928.6830.4957.3968.00
EV/Sales Ratio
5.443.904.215.054.8611.55
EV/EBITDA Ratio
21.4515.3719.1922.0617.0733.67
EV/EBIT Ratio
28.9920.7727.1029.4519.9036.32
EV/FCF Ratio
64.6646.3344.5747.14123.03181.96
Debt / Equity Ratio
0.030.030.030.040.000.00
Debt / EBITDA Ratio
0.170.170.250.280.000.00
Debt / FCF Ratio
0.530.530.590.610.030.02
Net Debt / Equity Ratio
-0.30-0.30-0.29-0.18-0.47-0.45
Net Debt / EBITDA Ratio
-1.93-1.93-2.14-1.21-3.64-2.15
Net Debt / FCF Ratio
-5.82-5.82-4.98-2.58-26.27-11.60
Asset Turnover
0.540.540.510.580.440.61
Inventory Turnover
1.411.411.441.401.161.79
Quick Ratio
3.313.313.012.616.587.80
Current Ratio
4.684.684.344.049.4610.06
Return on Equity (ROE)
10.53%10.53%7.82%9.26%10.33%18.55%
Return on Assets (ROA)
6.35%6.35%4.98%6.25%6.65%12.21%
Return on Invested Capital (ROIC)
12.20%12.33%8.39%11.67%16.14%30.73%
Return on Capital Employed (ROCE)
11.10%11.10%9.00%10.50%11.00%19.30%
Earnings Yield
2.70%3.68%2.66%2.54%3.74%2.25%
FCF Yield
1.42%1.93%2.02%2.00%0.69%0.52%
Dividend Yield
0.87%1.18%1.14%1.11%--
Payout Ratio
28.87%28.87%47.17%---
Buyback Yield / Dilution
-0.13%-0.13%-0.01%-0.03%-0.09%-3.96%
Total Shareholder Return
0.74%1.05%1.13%1.07%-0.09%-3.96%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.